Find clinical trials for Non-Small-Cell Lung Cancer in Kansas City, KS
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Kansas City, KS, USA:
Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mort...
Phase 2, Phase 3
Westwood, Kansas, United States and 27 other locations
participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC)....
Phase 1, Phase 2
Westwood, Kansas, United States and 9 other locations
Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive patients with squamous and non-squamous metastatic NSCLC with ICI...
Phase 3
Merriam, Kansas, United States and 54 other locations
This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...
Phase 2
Kansas City, Missouri, United States and 157 other locations
and in combination with pembrolizumab in patients with advanced non-small cell lung cancer and colorecta...
Phase 1
Kansas City, Kansas, United States and 14 other locations
provides improved patient outcomes compared to pembrolizumab alone in patients with previously treated locally advanced or metastatic non-sm ...
Phase 2
Kansas City, Missouri, United States and 32 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Kansas City, Kansas, United States and 252 other locations
Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) t...
Phase 2
Kansas City, Missouri, United States and 33 other locations
alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...
Phase 3
Kansas City, Kansas, United States and 152 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Kansas City, Missouri, United States and 286 other locations
Clinical trials
Research sites
Resources
Legal